Antazoline Hydrochloride/Tetryzoline Hydrochloride

盐酸安他唑啉/盐酸四氢唑啉

Report date: 2022/05/06 10:24:38

Base Information

Drug NameAntazoline Hydrochloride/Tetryzoline Hydrochloride

Drug Alias Nametetryzoline/antazoline盐酸安他唑啉+盐酸四氢唑啉盐酸四氢唑啉/盐酸安他唑啉Antazoline Hydrochloride+Tetryzoline HydrochlorideTetryzoline Hydrochloride+Antazoline Hydrochloride +[9]

ClassificationSmall molecules

Mechanisms of ActionHistamine H1 receptor antagonistsAdrenergic receptor alpha-1 agonists

TargetsHistamine H1 receptorAdrenergic receptors alpha-1

Therapy Area/IndicationsConjunctivitis, Allergic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryEgypt

CombinationsYes Antazoline Hydrochloride Tetryzoline Hydrochloride

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesOrchidia Pharmaceutical

China Registration ClassN/A

Develop Information

Active CompaniesOrchidia Pharmaceutical

Inactive CompaniesN/A

Active IndicationsConjunctivitis, Allergic

Inactive IndicationsN/A

Other Information

ATC CodeS01GA52